Kaicheng Zhu

Person

Belmont, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Antiviral heterocyclic compounds
- Patent number 12,006,326
- Issue date Jun 11, 2024
- Enanta Pharmaceuticals, Inc.
- Adam Szymaniak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processes for the preparation of 4,6,7-trifluoro-1H-indole-2-carbox...
- Patent number 12,006,291
- Issue date Jun 11, 2024
- Enanta Pharmaceuticals, Inc.
- Kaicheng Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzodiazepine derivatives as RSV inhibitors
- Patent number 11,912,695
- Issue date Feb 27, 2024
- Enanta Pharmaceuticals, Inc.
- Kaicheng Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antiviral heterocyclic compounds
- Patent number 11,572,367
- Issue date Feb 7, 2023
- Enanta Pharmaceuticals, Inc.
- Adam Szymaniak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antiviral heterocyclic compounds
- Patent number 11,505,558
- Issue date Nov 22, 2022
- Enanta Pharmaceuticals, Inc.
- Adam Szymaniak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzodiazepine derivatives as RSV inhibitors
- Patent number 11,254,664
- Issue date Feb 22, 2022
- Enanta Pharmaceuticals, Inc.
- Kaicheng Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Antiviral Heterocyclic Compounds
- Publication number 20240368176
- Publication date Nov 7, 2024
- Enanta Pharmaceuticals, Inc.
- Adam SZYMANIAK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS
- Publication number 20240360117
- Publication date Oct 31, 2024
- Enanta Pharmaceuticals, Inc.
- Kaicheng Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTAL FORMS OF AN ANTI-SARS COV-2 AGENT
- Publication number 20240132512
- Publication date Apr 25, 2024
- Enanta Pharmaceuticals, Inc.
- Kaicheng Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESSES FOR THE PREPARATION OF SUBSTITUTED SPIROOXINDOLE DERIVATIVES
- Publication number 20230295175
- Publication date Sep 21, 2023
- Enanta Pharmaceuticals, Inc.
- Kaicheng Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES FOR THE PREPARATION OF 4,6,7-TRIFLUORO-1H-INDOLE-2-CARBOX...
- Publication number 20230234922
- Publication date Jul 27, 2023
- Enanta Pharmaceuticals, Inc.
- Kaicheng Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIVIRAL HETEROCYCLIC COMPOUNDS
- Publication number 20230125803
- Publication date Apr 27, 2023
- Enanta Pharmaceuticals, Inc.
- Adam Szymaniak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIVIRAL HETEROCYCLIC COMPOUNDS
- Publication number 20220356189
- Publication date Nov 10, 2022
- Enanta Pharmaceuticals, Inc.
- Adam Szymaniak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS
- Publication number 20220227746
- Publication date Jul 21, 2022
- Enanta Pharmaceuticals, Inc.
- Kaicheng Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS
- Publication number 20200299286
- Publication date Sep 24, 2020
- Enanta Pharmaceuticals, Inc.
- Kaicheng Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Kaicheng Zhu

Person

Patents Grantslast 30 patents

Antiviral heterocyclic compounds

Processes for the preparation of 4,6,7-trifluoro-1H-indole-2-carbox...

Benzodiazepine derivatives as RSV inhibitors

Antiviral heterocyclic compounds

Antiviral heterocyclic compounds

Benzodiazepine derivatives as RSV inhibitors

Patents Applicationslast 30 patents

Antiviral Heterocyclic Compounds

BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS

CRYSTAL FORMS OF AN ANTI-SARS COV-2 AGENT

PROCESSES FOR THE PREPARATION OF SUBSTITUTED SPIROOXINDOLE DERIVATIVES

PROCESSES FOR THE PREPARATION OF 4,6,7-TRIFLUORO-1H-INDOLE-2-CARBOX...

ANTIVIRAL HETEROCYCLIC COMPOUNDS

ANTIVIRAL HETEROCYCLIC COMPOUNDS

BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS

BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS